Haemonetics CorporationHAENYSE
Loading
Year-over-year SG&A expense growth
Latest
5.85%
↑ 137% vs avg
Percentile
P85
Within normal range
Streak
2 qtr
Consecutive growthStable
Average
-15.83%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 5.85% |
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q3 2023 | -100.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q1 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | -100.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | -100.00% |
| Q1 2020 | -50.70% |
| Q4 2019 | 0.48% |
| Q3 2019 | 7.22% |
| Q2 2019 | -8.15% |
| Q1 2019 | 6.40% |
| Q4 2018 | -4.36% |
| Q3 2018 | 12.70% |
| Q2 2018 | -13.26% |
| Q1 2018 | -19.24% |
| Q4 2017 | 34.45% |
| Q3 2017 | 8.86% |
| Q3 2017 | -6.75% |
| Q1 2017 | 0.42% |
| Q4 2016 | 0.40% |
| Q4 2016 | -18.72% |
| Q3 2016 | 14.71% |
| Q1 2016 | -3.37% |